FPS
NEO icon

Fieldpoint Private Securities’s NeoGenomics NEO Stock Holding History

Fieldpoint Private Securities’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-160
Closed -$5K – 1713
2021
Q4 		$5K Sell
160
-125
-44% -$4.89K ﹤0.01% 1266
2021
Q3 		$14K Sell
285
-10
-3% -$463 ﹤0.01% 939
2021
Q2 		$12K Sell
295
-60
-17% -$2.66K ﹤0.01% 963
2021
Q1 		$17K Buy
355
+40
+13% +$2.08K ﹤0.01% 833
2020
Q4 		$17K Buy
+315
New +$14.2K ﹤0.01% 739

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fieldpoint Private Securities's NEO Position: Q1 2022 in Review

Fieldpoint Private Securities sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 160 shares — an estimated $5K sold.

Fieldpoint Private Securities first reported a position in NEO in Q4 2020 and held it in 5 quarters. The position peaked at $17K in Q1 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Fieldpoint Private Securities reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Fieldpoint Private Securities sold 160 NeoGenomics shares in Q1 2022, an estimated $5K.
  • Fieldpoint Private Securities first reported a position in NeoGenomics in Q4 2020 and held it in 5 quarters.
  • Fieldpoint Private Securities's NeoGenomics position peaked at $17K in Q1 2021.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Fieldpoint Private Securities's 13F filing for Q1 2022, filed 7 Apr 2022.